Form 4 for ALT Altimmune, Inc.
Accepted 2022-01-26 00:00:00 ET · period of report 2022-01-25 · accession 0001104659-22-007911 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-26 | 2022-01-25 | ALT | Drutz David | Dir | M - OptEx | $2.40 | +70 | 17.9K | +0.4% | +$168 |
| D | 2022-01-26 | 2022-01-25 | ALT | Drutz David | Dir | M - OptEx | $0.00 | -70 | 69 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2022-01-25 | M | A | 70 | $2.40 | 17,882 | D | — | — | |
| 2 | Derivative | Stock Options (option to buy) | 2022-01-25 | M | D | 70 | $0.00 | 69 | D | $2.40 · — to 2022-12-31 | 70 Common Stock, par value $0.0001 | (F2) This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018. (F3) This option is fully vested and exercisable as of the date hereof. |